By mediating the immunological process of atherosclerosis (Figures 3 and 4) and attenuating disease symptoms and progression, HSP27 has considerable therapeutic potential in the treatment of cardiovascular diseases. The gene discussed is HSPB1; the disease is atherosclerosis.